Acer Therapeutics to Develop Emetine as Potential COVID-19 Treatment in Collaboration with National Center for Advancing Translational Sciences, One of the National Institutes of Health

NEWTON, MA – May 11, 2020– Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials